Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
10/2012
10/04/2012WO2012134392A1 Process for the production of a pemetrexed salt
10/04/2012WO2012134252A2 Composition for renal cancer treatment and functional food containing cannabis semen extract
10/04/2012WO2012134251A2 Composition for pancreatic cancer treatment and composition for cosmetics containing nardostachyos rhizoma extract
10/04/2012WO2012134250A2 Composition for renal cancer treatment and composition for cosmetic containing nardostachyos rhizoma extract
10/04/2012WO2012134234A2 Use of hades as a negative modulator of akt
10/04/2012WO2012134170A2 Composition for lung cancer treatment and composition for cosmetics containing rubiae radix extract
10/04/2012WO2012134169A2 Composition for lung cancer treatment and functional food containing gleditsiae semen extract
10/04/2012WO2012134168A2 Composition for lung cancer treatment and composition for cosmetics containing lysimachiae foenumgraeci herba extract
10/04/2012WO2012134167A2 Composition for lung cancer treatment and functional food containing eriobotriae folium extract
10/04/2012WO2012134165A2 Composition for lung cancer treatment and composition for cosmetics containing psoraleae semen extract
10/04/2012WO2012134164A2 Composition for lung cancer treatment and functional food containing farfarae flos extract
10/04/2012WO2012134163A2 Composition for lung cancer treatment and composition for cosmetics containing nardostachyos rhizoma extract
10/04/2012WO2012133994A1 Method for screening for a cancer treatment agent using the interaction between pauf and a binding partner thereof
10/04/2012WO2012133914A1 Potentiator of cancer immunity containing rankl antagonist
10/04/2012WO2012133884A1 Pharmaceutical composition containing block copolymer comprising boric acid compound
10/04/2012WO2012133814A1 Therapeutic agent for cancer, and method for determining prognosis of cancer
10/04/2012WO2012133802A1 Novel furanone derivative
10/04/2012WO2012133733A1 Cancer cell proliferation inhibitor
10/04/2012WO2012133674A1 Method for removing tumorigenesis-causing cells among stem cells
10/04/2012WO2012133648A1 Novel preparation technique for higher-order structure that exhibits anti-cellular effect
10/04/2012WO2012133399A1 Immunosuppressive cell-capturing material and immunosuppressive cell-capturing column
10/04/2012WO2012133223A1 Matrix metalloprotease (mmp) production inhibitor for oral use
10/04/2012WO2012133114A1 Antitumor agent containing carbon dioxide as active ingredient
10/04/2012WO2012132369A1 Viral vector targeting cancer stem cells
10/04/2012WO2012131698A1 Process for preparing docetaxel and its hydrate
10/04/2012WO2012131633A1 Pyrazolo pyrimidine derivatives
10/04/2012WO2012131527A1 Antibody-drug conjugates
10/04/2012WO2012131501A1 Substituted benzimidazole compounds as cot kinase inhibitors
10/04/2012WO2012131487A2 Compositions and methods for the treatment of cancer
10/04/2012WO2012131468A1 Crystalline forms of fused amino pyridines as hsp90 inhibitors
10/04/2012WO2012131399A1 Therapeutic treatment
10/04/2012WO2012131301A1 Compositions and methods for treating, diagnosing and monitoring disease
10/04/2012WO2012131297A1 Pyrido [3',2' :4,5] thieno [3, 2-d] pyrimidin- 4 - ylamine derivatives and their therapeutical use
10/04/2012WO2012131096A1 Novel heterocyclic compounds as modulators of sphingolipid signaling and uses thereof
10/04/2012WO2012131079A1 Compounds inhibiting galectin-1 expression, cancer cell proliferation, invasion, and tumorigenesis
10/04/2012WO2012131048A1 Treatment and prognosis of solid tumour cancers
10/04/2012WO2012131035A1 Composition comprising docetaxel
10/04/2012WO2012130915A1 Spiroalkene carboxamide derivatives and their use as chemokine receptor modulators
10/04/2012WO2012130911A1 Bifunctional hydroxy-bisphosphonic acid derivatives
10/04/2012WO2012130906A1 Derivatives useful for the treatment or prevention of bone tumors
10/04/2012WO2012130905A1 Substituted benzimidazoles
10/04/2012WO2012130850A1 Tissue targeting by means of oncocidal bridged diphenyl derivatives for the selective treatment of sexual organ tumors
10/04/2012WO2012130609A1 New combination comprising n-acetyl-l-cysteine and its use
10/04/2012WO2012130481A1 INHIBITION OF NF-kB ACTIVITY BY TRITERPENE COMPOUNDS
10/04/2012WO2012130314A1 Composition comprising docetaxel
10/04/2012WO2012130166A1 1-(arylmethyl)quinazoline-2,4(1h,3h)-diones as parp inhibitors and the use thereof
10/04/2012WO2012130165A1 Liver cancer diagnosis marker and use thereof
10/04/2012WO2012130160A1 Aminopyridine derivatives containing acridine ring and use thereof
10/04/2012WO2012130159A1 Aminopyridine derivatives and uses thereof
10/04/2012WO2012130141A1 Method and composition for enhancing target cells uptake of therapeutic agents
10/04/2012WO2012129967A1 New aminopyridine compounds, the preparation method, the pharmaceutical compositions comprising these compounds and the uses thereof
10/04/2012WO2012129957A1 Several pharmaceutical formulations
10/04/2012WO2012129942A1 Chiral 3-hydroxypyrid-4-one derivative, and synthesis and use thereof
10/04/2012WO2012129914A1 3-amino-2-hydroxy-4-phenyl-valyl-isoleucine and preparation method and use thereof
10/04/2012WO2012129872A1 Biological product and method of preparing same
10/04/2012WO2012129859A1 Polyamine compounds and preparative mentods and uses thereof
10/04/2012WO2012129673A1 INHIBITORS OF 17ß-HSD1, 17ß-HSD3 AND 17ß-HSD10
10/04/2012WO2012129668A1 Antibodies against kidney associated antigen 1 and antigen binding fragments thereof
10/04/2012WO2012107416A3 Improved immunotherapy
10/04/2012WO2012106461A9 Combination therapy for treatment of cancer
10/04/2012WO2012106368A9 Methods for inhibiting prostate cancer
10/04/2012WO2012106343A3 Hdac inhibitors and therapeutic methods using the same
10/04/2012WO2012097121A9 Specific nnos inhibitors for the therapy and prevention of human melanoma
10/04/2012WO2012095509A8 Composition for accelerating alcohol metabolism and for reducing the risk of alcohol induced diseases
10/04/2012WO2012094541A3 Acoustically responsive particles with decreased cavitation threshold
10/04/2012WO2012092539A3 Antibodies to dll4 and uses thereof
10/04/2012WO2012092471A3 Novel tubulin inhibitors and methods of using the same
10/04/2012WO2012079578A8 Selective killing of cancer cells
10/04/2012WO2012078667A3 Compositions and methods relating to proliferative diseases
10/04/2012WO2012065022A3 Spiro-oxindole mdm2 antagonists
10/04/2012WO2012065019A3 Combination comprising pyridopyrimidinone inhibitors of pi3k alpha
10/04/2012WO2012061750A3 Peptide compositions that downregulate tlr-4 signaling pathway and methods of producing and using same
10/04/2012WO2012024083A9 Oxathiazine and dithiine oxides as inhibitors of sulfhydryl-dependent biomolecules
10/04/2012WO2011143524A3 Functional, cross-linked nanostructures for tandem optical imaging and therapy
10/04/2012US20120255045 Inducible small rna expression constructs for targeted gene silencing
10/04/2012US20120253041 New phenylalanine derivatives
10/04/2012US20120253020 Compositions and Methods for Identifying Agents Which Modulate PTEN Function and PI-3 Kinase Pathways
10/04/2012US20120252907 Diagnostic methods and kit for detecting cancer
10/04/2012US20120252904 Mitf as a marker for predisposition to cancer
10/04/2012US20120252889 Polyketide molecules as anticancer agents
10/04/2012US20120252883 Method and Composition to Increase Radiation-Induced Tumor Therapeutic Effects
10/04/2012US20120252881 Therapeutic agent for tumor
10/04/2012US20120252874 Methods for delivery of sirna to the spinal cord and therapies arising therefrom
10/04/2012US20120252871 Diagnosis and treatment of chronic lymphocytic leukemia (cll)
10/04/2012US20120252869 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
10/04/2012US20120252865 Carbamate derivatives in particular for the treatment of neurological disorders
10/04/2012US20120252864 Substituted isoindoline-1,3-dione derivatives
10/04/2012US20120252862 Dissolvable Film Strip Comprising Natural Components
10/04/2012US20120252861 Medical Compositions for Intravesical Treatment of Bladder Cancer
10/04/2012US20120252860 Novel N, N'-Hydrazino-bis-isatin Derivatives with Selective Activity Against Multidrug-Resistant Cancer Cells
10/04/2012US20120252857 Genotype specific methods for treating human subjects using 4-methylpyrazole
10/04/2012US20120252856 Pi3k/akt pathway subgroups in cancer: methods of using biomarkers for diagnosis and therapy
10/04/2012US20120252854 Crystalline forms of thiazolidinedione compound and its manufacturing method
10/04/2012US20120252849 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities
10/04/2012US20120252846 Buccal, polar and non-polar spray or capsule containing drugs for treating pain
10/04/2012US20120252843 Isoindoline compounds and methods of their use
10/04/2012US20120252840 Method of Treating Cancer
10/04/2012US20120252837 Bicyclic derivatives of azabicyclic carboxamides, preparation thereof and therapeutic use thereof
10/04/2012US20120252836 1,3-Dioxanes and Their Uses
10/04/2012US20120252835 Stable temsirolimus composition and process of preparing same
1 ... 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 ... 2211